Home / Multiple Sclerosis

Multiple Sclerosis

Please click on the following:

Please read these Terms of Use and Privacy Statement(collectively, the "Terms") carefully before using this Site. Clicking any of the box above indicates that you accept these Terms.

Are you interested in possibly participating in a clinical trial for Warm Autoimmune Hemolytic Anemia?

Following specialists treat  Multiple Sclerosis.

Overview

FDA Approved Medicines

  • FDA approved interferon beta-1a, sold as Rebif, manufactured by Serono Laboratories as subcutaneous injection for the treatment of relapsing forms of multiple sclerosis ( Multiple Sclerosis ) in year 2002.
  • FDA approved mitoxantrone hydrochloride, sold as Novantrone, manufactured by Immunex for reducing neurologic disability and/or the frequency of clinical relapses in patients with multiple sclerosis ( Multiple Sclerosis ) in year 2000.
  • FDA approved dalfampridine, sold as Ampyra, manufactured by Acorda for the improvement of walking in patients with multiple sclerosis ( Multiple Sclerosis ) in year 2010.
  • FDA approved teriflunomide, sold as Aubagio, manufactured by Sanofi Aventis for the treatment of multiple sclerosis ( Multiple Sclerosis ) in year 2012.
  • FDA approved Interferon Beta 1-A, sold as Avonex, manufactured by Biogen IDEC for the treatment of multiple sclerosis ( Multiple Sclerosis ) in year 1995.
  • FDA approved dimethyl fumarate, sold as Tecfidera, manufactured by Biogen Idec for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2013.
  • FDA approved alemtuzumab, sold as Lemtrada, manufactured by Genzyme for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2014.
  • FDA approved fingolimod, sold as Gilenya, manufactured by Novartis for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2010.
  • FDA approved Interferon beta-l b, sold as Extavia, manufactured by Novartis for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2009.
  • FDA approved peginterferon beta-1a, sold as Plegridy, manufactured by Biogen IDEC. for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2014.

Videos

No videos found

Blog(s)

Association between Zika virus and Guillain-Barre syndrome

Minstream journalism outlets and social media have recently been flooded with pictures of babies in South America born with heads smaller than the normal size, a condition known as microcephaly. This new epidemic was linked to the Zika virus, a virus that is transmitted to the pregnant mother by a mosquito bite and causes the deformity in the fetus. This virus is actually not as new as it seems, though. It has been documented in previous literature since the 1940s and has caused multiple outbreaks in both French Polynesia and Asia (1). However, because of the proximity to the USA of the recent outbreak caused by the virus in South America, the Zika virus has been thrust into the spotlight. 

Read More

Research

Recent research related to Multiple Sclerosis